MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following has announced the launch of its Favipiravir in India under the brand name Covihalt for the treatment of mild to moderate COVID-19? |
| A. | Sun Pharma |
| B. | Lupin Limited |
| C. | Biocon |
| D. | Aurobindo Pharma |
| E. | Zydus Cadila |
| Answer» C. Biocon | |